{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:48:16Z","timestamp":1780105696663,"version":"3.54.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.phrs.2012.02.011","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T10:02:08Z","timestamp":1332496928000},"page":"1-6","source":"Crossref","is-referenced-by-count":53,"title":["Haptoglobin genotype and its role in determining heme-iron mediated vascular disease"],"prefix":"10.1016","volume":"66","author":[{"given":"Hagit","family":"Goldenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina S.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (2)","key":"10.1016\/j.phrs.2012.02.011_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/ars.2009.2793","article-title":"Haptoglobin: basic and clinical aspects","volume":"12","author":"Levy","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"October (10)","key":"10.1016\/j.phrs.2012.02.011_bib0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and clinical significance of haptoglobin polymorphism in humans","volume":"42","author":"Langlois","year":"1996","journal-title":"Clin Chem"},{"issue":"March (4)","key":"10.1016\/j.phrs.2012.02.011_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.RES.0000156653.05853.b9","article-title":"Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo","volume":"96","author":"Asleh","year":"2005","journal-title":"Circ Res"},{"issue":"January (2)","key":"10.1016\/j.phrs.2012.02.011_bib0020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1074\/jbc.M411390200","article-title":"Assignment of the binding site for haptoglobin on apolipoprotein A-I","volume":"280","author":"Spagnuolo","year":"2005","journal-title":"J Biol Chem"},{"issue":"December (12)","key":"10.1016\/j.phrs.2012.02.011_bib0025","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/01.RES.0000251741.65179.56","article-title":"Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo","volume":"99","author":"Asleh","year":"2006","journal-title":"Circ Res"},{"issue":"June (2)","key":"10.1016\/j.phrs.2012.02.011_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mrd.1021","article-title":"Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid","volume":"59","author":"Balestrieri","year":"2001","journal-title":"Mol Reprod Dev"},{"issue":"May (5)","key":"10.1016\/j.phrs.2012.02.011_bib0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s001250051666","article-title":"Haptoglobin phenotype and diabetic nephropathy","volume":"44","author":"Nakhoul","year":"2001","journal-title":"Diabetologia"},{"issue":"September (13)","key":"10.1016\/j.phrs.2012.02.011_bib0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJM200009283431313","article-title":"Haptoglobin phenotype and vascular complications in patients with diabetes","volume":"343","author":"Levy","year":"2000","journal-title":"N Engl J Med"},{"issue":"February (3)","key":"10.1016\/j.phrs.2012.02.011_bib0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0002-9149(00)01368-0","article-title":"Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty","volume":"87","author":"Roguin","year":"2001","journal-title":"Am J Cardiol"},{"issue":"December (11)","key":"10.1016\/j.phrs.2012.02.011_bib0050","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0735-1097(02)02534-2","article-title":"Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the strong heart study","volume":"40","author":"Levy","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"September (9)","key":"10.1016\/j.phrs.2012.02.011_bib0055","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.26.9.2628","article-title":"Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes","volume":"26","author":"Roguin","year":"2003","journal-title":"Diabetes Care"},{"issue":"September (9)","key":"10.1016\/j.phrs.2012.02.011_bib0060","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.2337\/diabetes.54.9.2802","article-title":"Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction","volume":"54","author":"Suleiman","year":"2005","journal-title":"Diabetes"},{"issue":"February (2)","key":"10.1016\/j.phrs.2012.02.011_bib0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/ATVBAHA.107.153965","article-title":"Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial","volume":"28","author":"Milman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"June (6)","key":"10.1016\/j.phrs.2012.02.011_bib0070","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/db08-0095","article-title":"Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes","volume":"57","author":"Costacou","year":"2008","journal-title":"Diabetes"},{"issue":"November","key":"10.1016\/j.phrs.2012.02.011_bib0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1475-2840-10-99","article-title":"Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes","volume":"10","author":"Simpson","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"December (12)","key":"10.1016\/j.phrs.2012.02.011_bib0080","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.2337\/db09-0874","article-title":"Haptoglobin genotype and renal function decline in type 1 diabetes","volume":"58","author":"Costacou","year":"2009","journal-title":"Diabetes"},{"issue":"July\u2013August (4)","key":"10.1016\/j.phrs.2012.02.011_bib0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/dmrr.556","article-title":"Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus","volume":"21","author":"Miller-Lotan","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"issue":"June","key":"10.1016\/j.phrs.2012.02.011_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1475-2840-8-29","article-title":"Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice","volume":"8","author":"Asaf","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"January (1)","key":"10.1016\/j.phrs.2012.02.011_bib0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.ATV.0000251020.24399.a2","article-title":"Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque","volume":"27","author":"Levy","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"December (23)","key":"10.1016\/j.phrs.2012.02.011_bib0100","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1016\/S0021-9258(17)42604-4","article-title":"Hemoglobin A biologic fenton reagent","volume":"259","author":"Sadrzadeh","year":"1984","journal-title":"J Biol Chem"},{"issue":"June (3)","key":"10.1016\/j.phrs.2012.02.011_bib0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/152308604773934422","article-title":"Redox reactions of hemoglobin","volume":"6","author":"Rifkind","year":"2004","journal-title":"Antioxid Redox Signal"},{"issue":"February (2)","key":"10.1016\/j.phrs.2012.02.011_bib0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/ars.2009.2822","article-title":"Heme degradation and vascular injury","volume":"12","author":"Belcher","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"September (3)","key":"10.1016\/j.phrs.2012.02.011_bib0115","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1073\/pnas.56.3.974","article-title":"Exchange of heme among hemoglobin molecules","volume":"56","author":"Bunn","year":"1966","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (13)","key":"10.1016\/j.phrs.2012.02.011_bib0120","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood.V98.13.3693","article-title":"Structure\u2013function analysis of the antioxidant properties of haptoglobin","volume":"98","author":"Melamed-Frank","year":"2001","journal-title":"Blood"},{"issue":"April (13)","key":"10.1016\/j.phrs.2012.02.011_bib0125","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1021\/bi0362626","article-title":"Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL","volume":"43","author":"Bamm","year":"2004","journal-title":"Biochemistry"},{"issue":"September (9)","key":"10.1016\/j.phrs.2012.02.011_bib0130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nsmb1284","article-title":"The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction","volume":"14","author":"Wu","year":"2007","journal-title":"Nat Struct Mol Biol"},{"issue":"September (9)","key":"10.1016\/j.phrs.2012.02.011_bib0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpendmet0245","article-title":"Mechanisms of disease: Proatherogenic HDL \u2013 an evolving field","volume":"2","author":"Navab","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"July (1)","key":"10.1016\/j.phrs.2012.02.011_bib0140","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.107.149435","article-title":"Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability","volume":"101","author":"Levy","year":"2007","journal-title":"Circ Res"},{"issue":"October (10)","key":"10.1016\/j.phrs.2012.02.011_bib0145","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/db08-0450","article-title":"Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype","volume":"57","author":"Asleh","year":"2008","journal-title":"Diabetes"},{"issue":"September (13)","key":"10.1016\/j.phrs.2012.02.011_bib0150","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jacc.2008.06.029","article-title":"Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque","volume":"52","author":"Moreno","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"May (1)","key":"10.1016\/j.phrs.2012.02.011_bib0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.atherosclerosis.2011.01.028","article-title":"Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques","volume":"216","author":"Lioupis","year":"2011","journal-title":"Atherosclerosis"},{"issue":"May (20)","key":"10.1016\/j.phrs.2012.02.011_bib0160","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJM199305203282004","article-title":"Vitamin E consumption and the risk of coronary heart disease in men","volume":"328","author":"Rimm","year":"1993","journal-title":"N Engl J Med"},{"issue":"January (1)","key":"10.1016\/j.phrs.2012.02.011_bib0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis. High-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"issue":"July (1)","key":"10.1016\/j.phrs.2012.02.011_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2010.02.018","article-title":"The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes","volume":"211","author":"Blum","year":"2010","journal-title":"Atherosclerosis"},{"issue":"January (3)","key":"10.1016\/j.phrs.2012.02.011_bib0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients the heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"November (11)","key":"10.1016\/j.phrs.2012.02.011_bib0180","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2337\/diacare.27.11.2767","article-title":"The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes","volume":"27","author":"Levy","year":"2004","journal-title":"Diabetes Care"},{"issue":"November (1)","key":"10.1016\/j.phrs.2012.02.011_bib0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2011.06.005","article-title":"Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype","volume":"219","author":"Farbstein","year":"2011","journal-title":"Atherosclerosis"},{"issue":"April (4)","key":"10.1016\/j.phrs.2012.02.011_bib0190","doi-asserted-by":"crossref","first-page":"F830","DOI":"10.1152\/ajprenal.90655.2008","article-title":"Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus","volume":"296","author":"Nakhoul","year":"2009","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T15:47:37Z","timestamp":1641484057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661812000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1043661812000357"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2012.02.011","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}